Status Cancelled
Estimated value without VAT 210 000 MDL
Period of clarifications: 3 Jan 2022, 23:16 - 12 Jan 2022, 15:09
Submission of proposals: 12 Jan 2022, 15:09 - 20 Jan 2022, 19:09
Auction start date: 21 Jan 2022, 13:37

Supplier technical support:

(+373) 79999801

Stent de tip sinusoidal continuu fabricat dintr-un material metalic compozit, constând dintr-o carcasă din aliaj pe bază de cobalt și un miez de aliaj platină-iridiu; compatibil RMN. Substanța activă: Zotarolimus: Doza: 1,5-2 µg/mm2 pe lungimea stentului.Design modular, premontat pe balon semicompliant. Suprafata de sectiune circulara (asigura o mai buna acoperire a vasului) Compatibil cu cateter ghid de 5F (min. I.D.:1.4mm/ 0.056”). Sistema de delivrare 140 cm. Dimensiuni: 2.0-5.0 mm cu posibilitatea de postdilatare cu pina la 1,25 mm de la diametrul initial, lung. 8-38 mm.
Information about customer
Fiscal code/IDNO
Address
2025, MOLDOVA, mun.Chişinău, locality, str. Testimitanu 29/1
Web site
---
The contact person
Full name
Stoicev Tatiana
Contact phone
+37322256125
Purchase data
Date created
Date modified
10 Jan 2022, 19:38
Estimated value (without VAT)
210 000 MDL
The minimum downward of the price
2 100 MDL
Achizitii.md ID
21049592
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Delivery address
2025, MOLDOVA, mun.Chişinău, mun.Chişinău, Testemitanu 29/1
Contract period
27 Jan 2022 02:00 - 31 May 2022 03:00
List of positions
1)
Title
Stenturi coronariene cu eliberare de substanta antirestenoza- Zotarolimus CPV: 33100000-1 - Medical equipments
Quantity: 30.0
Unit of measurement: Bucata
Documents of the procurement procedure
dsbunuriservi
Technical Specifications
documentatia
3.01.22 23:16
duaero
Technical Specifications
DUAE
3.01.22 23:16
anunt de participare
Technical Specifications
Anunt de participare
3.01.22 23:16
declaratiero 4
Technical Specifications
declaratia
3.01.22 23:16
The history of the auction
View auction
Litigation
File an appeal
К сожалению, вопросы можно задавать только во время периода "Active".
Clarifications